Daiwa Securities Group
AMAM

Daiwa Securities Group’s Ambrx Biopharma Inc AMAM Stock Holding History

Daiwa Securities Group’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-258
Closed -$4K – 1366
2023
Q4 		$4K Buy
+258
New +$2.93K ﹤0.01% 1236

Daiwa Securities Group's AMAM Position: Q1 2024 in Review

Daiwa Securities Group sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 258 shares — an estimated $4K sold.

Daiwa Securities Group first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $4K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

  • Daiwa Securities Group reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 258 Ambrx Biopharma Inc shares in Q1 2024, an estimated $4K.
  • Daiwa Securities Group first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
  • Daiwa Securities Group's Ambrx Biopharma Inc position peaked at $4K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.